-
Founded in:
1997-12-10 -
Country:
China -
Address:
No. 111, Yixin Road, Shuangyang Economic Development Zone, Changchun -
Tax NO.:
912201012440638092 -
Registered Funds:
100 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| α-Mannan peptide |
No specific description provided
More
No specific description provided |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| PotassiuM sodiuM Dehydroandrographolide Succinate |
|
863319-40-8 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| PotassiuM sodiuM Dehydroandrographolide Succinate |
Extract from the above information
More
Extract from the above information |
863319-40-8 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dacarbazine |
This product has anti-tumor effects. Since it is a precursor of purine biosynthesis, it can interfere with purine biosynthesis. After entering the body, it demethylates to form monomethyl compounds in liver microsomes, which have direct cytotoxic effects. It mainly acts on the G2 phase. It inhibits the synthesis of purine, RNA and protein, and also affects the synthesis of DNA. Therefore, it is also considered to be an alkylating anti-tumor drug.
More
This product has anti-tumor effects. Since it is a precursor of purine biosynthesis, it can interfere with purine biosynthesis. After entering the body, it demethylates to form monomethyl compounds in liver microsomes, which have direct cytotoxic effects. It mainly acts on the G2 phase. It inhibits the synthesis of purine, RNA and protein, and also affects the synthesis of DNA. Therefore, it is also considered to be an alkylating anti-tumor drug. |
4342-03-4 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acipimox |
Acipimox is a derivative of nicotinic acid, which can inhibit the decomposition of adipose tissue, reduce the release of free fatty acids from adipose tissue, thereby reducing the synthesis of triglycerides (TG) in the liver, and by inhibiting the synthesis of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), the concentration of triglycerides (TG) and total cholesterol (TC) in the blood decreases. This product can also inhibit the activity of liver lipase and reduce the decomposition of high-density lipoprotein (HDL).
More
Acipimox is a derivative of nicotinic acid, which can inhibit the decomposition of adipose tissue, reduce the release of free fatty acids from adipose tissue, thereby reducing the synthesis of triglycerides (TG) in the liver, and by inhibiting the synthesis of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), the concentration of triglycerides (TG) and total cholesterol (TC) in the blood decreases. This product can also inhibit the activity of liver lipase and reduce the decomposition of high-density lipoprotein (HDL). |
51037-30-0 | 7 |